These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report. Kitahara C; Morita S; Kishimoto S; Matsuno S; Uraki S; Takeshima K; Furukawa Y; Inaba H; Iwakura H; Ariyasu H; Furuta H; Nishi M; Akamizu T J Diabetes Investig; 2021 Apr; 12(4):664-667. PubMed ID: 32686282 [TBL] [Abstract][Full Text] [Related]
46. Sodium glucose co-transporter-2 inhibitor-induced diabetic ketoacidosis following tooth extraction: improving awareness among dental practitioners. Yap SD; Hamblin PS; Bach L; Ekinci E; Wong R Aust Dent J; 2021 Dec; 66(4):444-447. PubMed ID: 34432892 [TBL] [Abstract][Full Text] [Related]
47. Euglycaemic diabetic ketoacidosis in a patient with type 2 diabetes started on empagliflozin. Rashid O; Farooq S; Kiran Z; Islam N BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27177938 [TBL] [Abstract][Full Text] [Related]
48. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression. Musso G; Sircana A; Saba F; Cassader M; Gambino R PLoS Med; 2020 Dec; 17(12):e1003461. PubMed ID: 33373368 [TBL] [Abstract][Full Text] [Related]
49. A Retrospective Analysis of Children and Adolescents With Diabetic Ketoacidosis in the Intensive Care Unıt: Is It Significant that the Blood Ketone Level Becomes Negative in Diabetic Ketoacidosis? Kangin M; Talay MN; Tanriverdi Yilmaz S; Unal E; Demiral M; Asena M; Ozbek MN Cureus; 2020 Oct; 12(10):e10844. PubMed ID: 33178500 [TBL] [Abstract][Full Text] [Related]
50. Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis. Calçada MB; Fernandes L; Soares Costa R; Montezinho S; Martins Duarte F; Frutuoso L; Freitas AR Clin Pract; 2021 Apr; 11(2):216-218. PubMed ID: 33917274 [TBL] [Abstract][Full Text] [Related]
51. Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Bariatric Surgery: A Case and Literature Review. Kapila V; Topf J Cureus; 2021 Aug; 13(8):e17093. PubMed ID: 34527480 [TBL] [Abstract][Full Text] [Related]
52. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report. Alkatheeri A; Alseddeeqi E J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357 [TBL] [Abstract][Full Text] [Related]
53. A Case of Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus and COVID-19. Morrison N; Barnett K; Tantum J; Morrison HK; Whalen M Cureus; 2020 Dec; 12(12):e12029. PubMed ID: 33457131 [TBL] [Abstract][Full Text] [Related]
54. Ketogenic Diet-Induced Diabetic Ketoacidosis in a Young Adult with Unrecognized Type 1 Diabetes. Charoensri S; Sothornwit J; Trirattanapikul A; Pongchaiyakul C Case Rep Endocrinol; 2021; 2021():6620832. PubMed ID: 33628529 [TBL] [Abstract][Full Text] [Related]
55. Sudden-onset Hypoglycemia Following Fluid Replacement in a Patient with Dapagliflozin-induced Diabetic Ketoacidosis Without Prior Insulin Use: Case Report. Elshimy G; Correa R Cureus; 2019 Aug; 11(8):e5448. PubMed ID: 31489272 [TBL] [Abstract][Full Text] [Related]
56. Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor. Alhemeiri M; Alseddeeqi E Case Rep Endocrinol; 2022; 2022():4101975. PubMed ID: 35282610 [TBL] [Abstract][Full Text] [Related]
57. Isoproterenol Induced Insulin Resistance Leading to Diabetic Ketoacidosis in Type 1 Diabetes Mellitus. Hoff R; Koh CK Case Rep Endocrinol; 2018; 2018():4328954. PubMed ID: 30647979 [TBL] [Abstract][Full Text] [Related]
58. Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis. Colacci M; Fralick J; Odutayo A; Fralick M Can J Diabetes; 2022 Feb; 46(1):10-15.e2. PubMed ID: 34116926 [TBL] [Abstract][Full Text] [Related]
59. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer. Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940 [TBL] [Abstract][Full Text] [Related]
60. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report. Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]